Could zapping kidney nerves tame stubborn high blood pressure and save hearts?

NCT ID NCT07602790

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a procedure called renal denervation, which uses a catheter to calm overactive nerves in the kidneys, in 1,000 people with both resistant hypertension and multivessel coronary artery disease. Participants will undergo the procedure during a planned heart stent operation and be followed for heart attacks, strokes, hospitalizations, and blood pressure changes. The goal is to see if this nerve treatment can reduce serious heart events better than standard blood pressure medications alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

renal denervation procedure

What this could lead to

If it works, this could offer a new way to control blood pressure and reduce heart attacks, strokes, and hospitalizations in people with both resistant hypertension and severe coronary artery disease.

What could go wrong

This is an early-stage study with no phase assigned, so results are uncertain. The procedure carries risks like kidney artery damage or contrast-related kidney injury, and it may not lower blood pressure enough to prevent heart events.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIVESSEL CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder Hypertension Resistant to Conventional Therapy resistant hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••